Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (685)
|
Core Tip (773)
|
Full Article (HTML) (2541)
|
Figures (1-1) (508)
|
Full Article (PDF)-1204K (213)
|
Full Article with Cover (PDF)-11949K (254)
|
Full Article (XML)-236K (132)
|
Audio-1342K (11)
|
Peer-Review Report-230K (146)
|
Answering Reviewers-97K (133)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (7942)
|
Similar Articles (78)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (723)
|
Core Tip (768)
|
Full Article (HTML) (1847)
|
Tables (1-1) (584)
|
Full Article (PDF)-358K (172)
|
Full Article with Cover (PDF)-11106K (226)
|
Full Article (XML)-54K (119)
|
Audio-1072K (14)
|
Peer-Review Report-236K (111)
|
Answering Reviewers-62K (108)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6481)
|
Similar Articles (21)
|
Timeline of Article Publication (1)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions
World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (832)
|
Core Tip (664)
|
Full Article (HTML) (7098)
|
Figures (1-2) (546)
|
Tables (1-5) (543)
|
Full Article (PDF)-1655K (296)
|
Full Article with Cover (PDF)-12399K (253)
|
Full Article (XML)-226K (143)
|
Audio-1259K (13)
|
Peer-Review Report-216K (127)
|
Answering Reviewers-145K (121)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (20)
|
Total Visits (12247)
|
Similar Articles (67)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (797)
|
Core Tip (713)
|
Full Article (HTML) (3861)
|
Figures (1-1) (542)
|
Full Article (PDF)-601K (294)
|
Full Article with Cover (PDF)-11346K (183)
|
Full Article (XML)-89K (134)
|
Audio-384K (13)
|
Peer-Review Report-180K (113)
|
Answering Reviewers-74K (127)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (23)
|
Total Visits (8578)
|
Similar Articles (344)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (768)
|
Core Tip (684)
|
Article Highlights (694)
|
Full Article (HTML) (2618)
|
Figures (1-4) (483)
|
Tables (1-3) (485)
|
Full Article (PDF)-1672K (186)
|
Full Article with Cover (PDF)-12418K (178)
|
Full Article (XML)-173K (117)
|
Audio-467K (8)
|
Peer-Review Report-182K (109)
|
Answering Reviewers-71K (145)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8801)
|
Similar Articles (2106)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (732)
|
Core Tip (740)
|
Article Highlights (851)
|
Full Article (HTML) (2250)
|
Figures (1-3) (558)
|
Tables (1-2) (524)
|
Full Article (PDF)-1874K (193)
|
Full Article with Cover (PDF)-12619K (211)
|
Full Article (XML)-114K (139)
|
Audio-386K (20)
|
Peer-Review Report-233K (129)
|
Answering Reviewers-161K (126)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (10291)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication
World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (645)
|
Core Tip (614)
|
Article Highlights (685)
|
Full Article (HTML) (1622)
|
Figures (1-4) (466)
|
Full Article (PDF)-5746K (176)
|
Full Article with Cover (PDF)-16492K (172)
|
Full Article (XML)-96K (128)
|
Audio-3997K (11)
|
Peer-Review Report-192K (114)
|
Answering Reviewers-146K (126)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7072)
|
Similar Articles (43)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (720)
|
Core Tip (696)
|
Article Highlights (759)
|
Full Article (HTML) (2810)
|
Figures (1-4) (462)
|
Tables (1-5) (487)
|
Full Article (PDF)-6006K (209)
|
Full Article with Cover (PDF)-16750K (207)
|
Full Article (XML)-200K (121)
|
Audio-376K (9)
|
Peer-Review Report-182K (130)
|
Answering Reviewers-60K (131)
|
Supplementary Material-355K (123)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (11057)
|
Similar Articles (1950)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (648)
|
Core Tip (712)
|
Article Highlights (704)
|
Full Article (HTML) (1982)
|
Figures (1-4) (493)
|
Tables (1-4) (483)
|
Full Article (PDF)-5941K (177)
|
Full Article with Cover (PDF)-16687K (185)
|
Full Article (XML)-115K (126)
|
Audio-187K (10)
|
Peer-Review Report-215K (124)
|
Answering Reviewers-37K (137)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (8668)
|
Similar Articles (2608)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (691)
|
Core Tip (709)
|
Full Article (HTML) (1745)
|
Figures (1-1) (542)
|
Full Article (PDF)-5068K (200)
|
Full Article with Cover (PDF)-15813K (174)
|
Full Article (XML)-63K (117)
|
Audio-811K (4)
|
Peer-Review Report-266K (129)
|
Answering Reviewers-225K (128)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7411)
|
Similar Articles (4451)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (686)
|
Core Tip (738)
|
Full Article (HTML) (1707)
|
Full Article (PDF)-325K (149)
|
Full Article with Cover (PDF)-11079K (175)
|
Full Article (XML)-24K (126)
|
Audio-243K (4)
|
Peer-Review Report-215K (98)
|
Answering Reviewers-19K (104)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5325)
|
Similar Articles (403)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
